Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-96.25	-65.66	-33.46
Graham Fair Price	41.50	0.12	0.08
PEG	-49.93	0.27	-0.54
Price/Book	22.39	0.48	0.39
Price/Cash Flow	-28.13	2.69	3.74
Prices/Earnings	-38.80	24.18	39.52
Price/Sales	-51.58	8.76	18.09
Price/FCF	-28.13	2.69	3.74
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-9.19	0.91	1.00
Operating Margin	-37.94	0.09	-0.15
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	21.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.28	2.57	101.08
EPS QOQ	-0.73	0.89	22.22
FCF QOQ	1.12	0.70	-36.97
Revenue QOQ	-0.60	1.53	153.53
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	751.43	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	< 0.005	100.00
Quick Ratio	286.02	3.35	-98.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.35	0.35	0.06
Cash	0.20	0.34	64.30
Capex	< 0.005	< 0.005	-100.11
Free Cash Flow	0.04	0.06	70.39
Revenue	< 0.005	0.02	152.92
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	286.02	3.36	-98.83
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-102.41	-132.01	-28.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating